Temperature Management Market Size and Share

Temperature Management Market Analysis by Mordor Intelligence
The temperature management market size stood at USD 3.33 billion in 2026 and is projected to reach USD 4.03 billion by 2031, reflecting a 3.89% CAGR during the forecast period. The steady headline growth conceals fast-moving shifts: artificial-intelligence (AI) algorithms that predict core temperature deviations, a resurgence of forced-air warming in outpatient surgery, and rising procurement of portable cooling systems for heat emergencies are redrawing competitive boundaries across the temperature management market. Hospitals are modernizing fleets to comply with updated Joint Commission perioperative-normothermia standards, while tariff shocks on Chinese components are prompting manufacturers to reshore supply chains. Simultaneously, Class I and II recalls have undermined confidence in older devices and opened opportunities for dual-mode intravascular-surface platforms that promise tighter control, faster ramp rates, and closed-loop automation.
Key Report Takeaways
- By product type, Patient Cooling Systems held 48.81% of temperature management market share in 2025, yet Patient Warming Systems are forecast to expand at a 5.12% CAGR through 2031.
- By application, Perioperative Care accounted for 41.45% of the temperature management market size in 2025, while Neonatal and Pediatric Care is projected to grow at a 5.21% CAGR to 2031.
- By end user, Hospitals led with 68.83% of temperature management market share in 2025; Long-Term and Home-care Settings record the fastest expected CAGR at 4.98% through 2031.
- By geography, North America captured 41.45% revenue share in 2025, whereas Asia-Pacific is anticipated to post the highest CAGR at 5.05% to 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Global Temperature Management Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising prevalence of chronic & acute conditions requiring temperature control | +1.2% | Global, with concentration in North America and Europe due to aging populations | Medium term (2-4 years) |
| Growing global surgical volumes | +0.9% | Asia-Pacific core, spill-over to Middle East and South America | Short term (≤ 2 years) |
| Technological advances in intravascular & surface systems | +0.8% | North America & EU (early adoption), APAC (diffusion phase) | Long term (≥ 4 years) |
| AI-driven predictive thermoregulation adoption in ICUs | +0.5% | North America, select EU markets (Germany, UK), pilot programs in Asia-Pacific | Long term (≥ 4 years) |
| Climate-change-induced surge in heat-illness emergencies | +0.4% | Global, acute in Southern U.S., Mediterranean Europe, Middle East, South Asia | Short term (≤ 2 years) |
| Portable TTM devices for pre-hospital / battlefield care | +0.3% | North America (EMS, military), EU (emergency services), emerging in APAC | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Rising Prevalence of Chronic & Acute Conditions Requiring Temperature Control
Cardiovascular disease, stroke, and sepsis together prompted more than 30 million OECD hospitalizations in 2025, and all three benefit from precise temperature modulation to curtail neurological damage, coagulopathy, or organ failure. American Heart Association guidelines updated in 2024 require 32-36 °C cooling for 24 hours after cardiac arrest to reduce neurological sequelae.[1]American Heart Association, “2024 Guidelines for Post-Cardiac Arrest Care,” ahajournals.org CDC data show 1.7 million U.S. sepsis hospitalizations in 2024; controlled normothermia lowers mortality by up to 12% in randomized trials.[2]Centers for Disease Control and Prevention, “Sepsis Hospitalizations 2024,” cdc.gov Asia-Pacific now records 13 million new strokes yearly, and early cooling within 6 hours improves 90-day outcomes, driving hospitals to expand device fleets. This epidemiological wave is expanding the temperature management market, particularly in neurocritical-care and cardiac-arrest units that demand rapid, servo-controlled systems. Procurement committees weigh evidence of shorter intensive-care stays and lower ventilator days when proactive temperature control is implemented.
Growing Global Surgical Volumes
Worldwide surgical procedures rebounded to roughly 400 million in 2024, exceeding pre-pandemic levels. Perioperative hypothermia below 36 °C occurs in up to 70% of patients under general anesthesia and heightens infection risk, transfusion requirements, and recovery times. The American Society of Anesthesiologists mandated active warming for procedures lasting more than 30 minutes in its 2024 advisory. Asia-Pacific leads growth: China performed 60 million inpatient surgeries in 2024 and India expanded capacity 12% year-over-year as district-level theaters opened. U.S. ambulatory surgical centers logged 28 million cases in 2024, adopting forced-air and conductive devices to meet Joint Commission norms. The temperature management market gains momentum as bariatric, robotic, and minimally invasive surgeries extend operative time and diminish endogenous heat production.
Technological Advances in Intravascular & Surface Systems
Intravascular temperature management circulates chilled or warmed saline through central venous catheters, achieving ±0.2 °C precision and reducing shivering versus surface pads. ZOLL’s Thermogard XP, cleared by the FDA in January 2024, unites intravascular and surface modalities and runs closed-loop algorithms tied to esophageal or bladder probes. Hydrogel surface pads now conform to complex anatomy, eliminating forced-air contamination concerns. A 2024 Journal of Neurosurgery trial found intravascular cooling cut time-to-target temperature by 40% in traumatic brain injury, improving discharge Glasgow scores. Hybrid operating rooms prefer dual-mode platforms that swap warming and cooling during cardiothoracic repairs or extracorporeal-membrane-oxygenation (ECMO) explantation. Forward-looking suppliers market energy-efficient compressors and quieter pumps to win capital-equipment tenders that increasingly score on total cost of ownership.
AI-Driven Predictive Thermoregulation Adoption in ICUs
Machine-learning models digest real-time bedside data to forecast core temperature 60 minutes ahead with ≤0.2 °C error, empowering nurses to intervene early. A 2024 Critical Care Medicine study across six hospitals cut fever spikes >38.5 °C by 30% in septic-shock patients via automated alerts. Transformer networks extended prediction to 4 hours in post-operative ICUs, lowering hypothermic episodes 22% in 2025 trials. Implementation hurdles persist: legacy monitors lack Health-Level 7 Fast Healthcare Interoperability Resources (HL7-FHIR) connectors, and the FDA has yet to issue tailored guidance specific to AI temperature-prediction software. Hospitals with interoperable infrastructure nonetheless view predictive algorithms as a path to lower ventilator days and shorter ICU length of stay, supporting incremental investment in supportive hardware.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High acquisition & maintenance costs | -0.6% | Global, acute in emerging markets and smaller ASCs | Short term (≤ 2 years) |
| Product recalls & device failures | -0.4% | North America & EU (stringent reporting), ripple effect in APAC | Medium term (2-4 years) |
| Tariff-driven component price volatility | -0.3% | Global supply chains, manufacturers sourcing from China | Short term (≤ 2 years) |
| Infection-control litigation slowing forced-air adoption | -0.2% | North America (litigation-prone), EU (regulatory scrutiny) | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
High Acquisition & Maintenance Costs
Advanced intravascular units list between USD 25,000 and USD 40,000, and disposable catheters cost USD 800–1,200 per patient, pressuring budgets under value-based payment. The American Hospital Association reported 62% of U.S. hospitals deferred capital purchases in 2024, placing temperature devices among the top-10 delayed categories. Ambulatory centers favor USD 10–15 forced-air blankets over high-capex alternatives to preserve margins. Service contracts add 8–12% of purchase price annually, covering calibration and software patches. Import duties and currency swings elevate landed costs in emerging markets; an Indian hospital buying a USD 30,000 system pays up to 30% extra in tariffs and logistics, lifting final outlay above USD 38,000. Such economics elongate replacement cycles and impede penetration in mid-tier facilities.[3]American Hospital Association, “Annual Survey 2024,” aha.org
Product Recalls & Device Failures
The FDA’s MAUDE database logged 200-plus adverse-event reports in 2024–2025 concerning temperature devices, citing overheating, sensor drift, and software crashes. Augustine Surgical recalled Hot Dog mattresses in December 2024 after three burn cases; ZOLL recalled its Arctic Sun 5000 in June 2024 over unintended rewarming in 12 patients. Recalls foster clinician skepticism, trigger procurement moratoria, and expose manufacturers to liability. A class-action lawsuit filed in 2024 alleges forced-air systems compromise sterile fields, though discovery continues. Procurement teams now diversify vendor panels and favor dual-mode systems with built-in redundancy, reshaping competitive share in the temperature management market.
Segment Analysis
By Product Type: Warming Systems Outpace Cooling Despite Smaller Base**
Patient Warming Systems, propelled by the perioperative rebound and updated ASA mandates, are forecast to increase at a 5.12% CAGR from 2026 to 2031. Forced-Air Warming maintains leadership due to USD 10–15 disposables and rapid deployment, yet infection-control concerns in orthopedic and cardiac theaters nurture conductive-blanket uptake. Blood and IV-Fluid Warmers gain momentum in trauma centers where rapid transfusion of cold blood risks coagulopathy. The temperature management market size for warming devices is projected to reach USD 1.95 billion by 2031, yet dual-mode innovators threaten forced-air incumbents with integrated precision and reduced airborne-particle load. Accessories and disposables dominate recurring revenue, locking institutions into single-supplier service contracts that enhance lifetime value.
Patient Cooling Systems continue to hold 48.81% of 2025 revenue but face headwinds from recent recalls and capital-budget scrutiny. Surface gel-pad systems remain ICU staples for fever management, whereas intravascular catheters capture neurology and cardiac-arrest protocols demanding ±0.2 °C control. The temperature management market share for surface cooling is expected to erode 2 percentage points by 2031 as dual-mode platforms proliferate. Evaporative units see renewed interest as emergency-department stock for heat-stroke spikes documented by the CDC. Integrated dual-mode designs, such as Thermogard XP, are carving niches in hybrid rooms where aortic arch repair alternates between deep hypothermia and rapid rewarming.

Note: Segment shares of all individual segments available upon report purchase
By Application: Neonatal Care Surges on WHO Mandate
Neonatal and Pediatric Care leads growth at a 5.21% CAGR on the strength of WHO 2024 guidelines promoting 33.5 °C cooling for hypoxic-ischemic encephalopathy within 6 hours of birth. Cochrane evidence indicates a 75% drop in mortality or severe disability, compelling hospitals to install servo-controlled blankets and caps. The temperature management market size for neonatal applications is forecast to climb from USD 420 million in 2026 to USD 540 million in 2031. Emerging markets add incremental volume as philanthropic funding equips district hospitals. Specialized disposables sized for low birth weight infants contribute attractive margins.
Perioperative Care, with 41.45% share in 2025, remains the largest application by installed base. Implementation of Joint Commission audits pushes facilities to document core temperatures every 15 minutes, ensuring active warming adoption remains high. Cardiac Arrest & Critical Care is stable, yet adoption of intravascular cooling spreads from tertiary centers to regional hospitals as evidence of neurological benefit matures. Neurology & Stroke applications grow in Asia-Pacific, leveraging national subsidies for stroke centers. The “Others” bucket—burn units, transplant teams, military trauma—expands modestly, particularly as portable warming blankets become standard in mass-casualty kits.
By End User: Home Care Gains as Reimbursement Shifts
Hospitals commanded 68.83% of 2025 revenue, but value-based care incentives accelerate transfers to step-down units and home recovery. Ambulatory Surgical Centers, performing 28 million U.S. procedures in 2024, adopt low-cost forced-air blankets to maintain competitiveness. Long-Term and Home-care Settings grow fastest at a 4.98% CAGR; Medicare Advantage plans reimburse disposable conductive blankets paired with cloud-linked sensors that alert clinicians to hypothermia. The temperature management market share for home settings is expected to double from 3% to 6% of global revenue by 2031. Military and disaster-response users add incremental growth through contracts for ruggedized, battery-operated coolers and warmers.
Remote monitoring pilots in 2024 proved 18% fewer 30-day readmissions for orthopedic patients discharged with wearable warmers and Bluetooth thermometers. FDA draft guidance for home-use Software-as-a-Medical-Device eased regulatory pathways in late 2024, sparking start-up interest in app-based platforms. Long-term-care facilities deploy conductive blankets to offset elderly thermoregulatory deficits and reduce hypothermia-related falls, supporting steady demand.

Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America retained 41.45% of 2025 revenue, bolstered by 50 million surgical procedures and early AI adoption in academic ICUs. The CDC heat-illness surge has pushed emergency departments to secure portable cooling devices, enlarging the temperature management market. Device recalls have forced procurement diversification, benefitting mid-tier vendors and spurring hospitals to negotiate dual-source contracts. Canada funds therapeutic hypothermia under provincial budgets, while Mexico’s private chains add dual-mode systems to new hybrid theaters.
Asia-Pacific posts the highest regional CAGR at 5.05% for 2026–2031. China’s CNY 1.55 trillion healthcare spend earmarks 1,000 county hospitals for surgical upgrades, each stipulating perioperative temperature control equipment. India’s district-hospital expansion fuels forced-air blanket purchases, and private chains invest in intravascular cooling for neurocritical hubs. Japan’s aging demographic elevates stroke-cooling demand, aided by 2024 reimbursement codes. South Korea leverages subsidies for domestic startups developing AI-integrated platforms. Australia’s bushfire seasons heighten procurement of portable cooling units for emergency-department surge capacity.
Europe maintains significant share despite Medical Device Regulation (MDR) transition costs. Germany’s Diagnosis-Related-Group codes incentivize therapeutic hypothermia post-cardiac arrest. NHS England’s net-zero procurement policy favors energy-efficient conductive devices, nudging market share away from high-wattage forced-air systems. Heat-wave mortality in Italy and Spain catalyzes bulk orders for mobile cooling. Compliance hurdles under MDR have delayed small-firm launches, consolidating share among MDR-ready incumbents.
The Middle East & Africa benefit from mega-hospital projects under Saudi Vision 2030 and UAE Health Strategy 2025, each ICU bed budgeted with integrated temperature management systems. Field hospitals in Gulf nations now include industrial evaporative coolers for heat-stroke mass-casualty events. South Africa issues neonatal cooling tenders to cut birth-asphyxia deaths. South America records steady growth as Brazil’s SUS funds perioperative warming upgrades and Argentina’s private network chases accreditation.

Competitive Landscape
Medtronic bundles warming blankets with patient monitors, while ZOLL positions Thermogard XP as a dual-mode premium alternative. Gentherm’s 2016 purchase of Cincinnati Sub-Zero integrated Blanketrol coolers into a broader lineup, and ICU Medical’s USD 2.4 billion Smiths Medical buy added level-1 warmers and temperature probes. Emerging firms like Belmont Medical and The 37Company challenge incumbents with modular systems priced 15-20% lower and backed by cloud-analytics dashboards.
Regulatory dynamics shape strategy. EU MDR compliance expenses push smaller players to partner or exit Europe. U.S. tariff hikes on Chinese parts drive nearshore production. Energy-efficiency scoring in UK NHS tenders favors conductive solutions, prompting redesign of forced-air blowers. AI-driven predictive modules represent white space; no device maker yet markets an FDA-cleared forecasting algorithm despite promising trials. Recalls of forced-air and cooling systems tilt preference toward conductive blankets and intravascular catheters, altering purchase criteria in favor of proven safety records.
Supply-chain resilience features prominently in 2025-2026 roadmaps. ZOLL expanded a Texas PCB facility to hedge tariff risk, while Gentherm invested in an Ohio catheter plant. Vendors pursue ecosystem lock-in: capital equipment discounted upfront, balanced by higher-margin disposables under multiyear agreements. Hospitals weigh interoperability, lifecycle cost, and energy footprint alongside precision, cementing a nuanced competitive chessboard.
Temperature Management Industry Leaders
Becton, Dickinson and Company
Medtronic PLC
Stryker Corporation
Drägerwerk AG & Co. KGaA
Solventum
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- December 2024: Augustine Surgical recalled Hot Dog warming mattresses following patient burn reports, adding auto-shutoff upgrades.
- September 2024: USTR imposed 25–50% tariffs on medical-device components imported from China, squeezing manufacturer margins.
- June 2024: ZOLL initiated a Class II recall of Arctic Sun 5000 after software faults caused unintended rewarming in 12 post-arrest cases.
- January 2024: ZOLL Medical obtained FDA 510(k) clearance for Thermogard XP, a dual-mode intravascular-surface platform with real-time closed-loop control.
Global Temperature Management Market Report Scope
As per the scope of the report, temperature management devices are used to manage the human body temperature by providing regulations in inside recovery rooms, operations theaters, and other types of hospital rooms. With the rising number of surgeries performed in hospitals worldwide, there is a growing demand for these devices.
The Temperature Management Market is Segmented by Product Type (Patient Warming Systems and Patient Cooling Systems), Application (Cardiology, Orthopedics, Neurology, and Others), End-User (Operating Rooms, Intensive Care Units, Emergency Rooms, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (USD million) for the above segments.
| Patient Warming Systems | Forced-air Warming Devices |
| Conductive / Resistive Warming Devices | |
| Blood & IV-Fluid Warmers | |
| Integrated Dual-Mode Systems | |
| Patient Cooling Systems | Surface Cooling Devices |
| Intravascular Cooling Systems | |
| Evaporative / Air Cooling Systems | |
| Accessories & Disposables |
| Perioperative Care |
| Cardiac Arrest & Critical Care |
| Neurology & Stroke |
| Neonatal and Pediatric Care |
| Others |
| Hospitals |
| Ambulatory Surgical Centers |
| Long-Term and Home-care Settings |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Product Type | Patient Warming Systems | Forced-air Warming Devices |
| Conductive / Resistive Warming Devices | ||
| Blood & IV-Fluid Warmers | ||
| Integrated Dual-Mode Systems | ||
| Patient Cooling Systems | Surface Cooling Devices | |
| Intravascular Cooling Systems | ||
| Evaporative / Air Cooling Systems | ||
| Accessories & Disposables | ||
| By Application | Perioperative Care | |
| Cardiac Arrest & Critical Care | ||
| Neurology & Stroke | ||
| Neonatal and Pediatric Care | ||
| Others | ||
| By End User | Hospitals | |
| Ambulatory Surgical Centers | ||
| Long-Term and Home-care Settings | ||
| Others | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
How large is the global temperature management market in 2026?
The temperature management market size reached USD 3.33 billion in 2026 and is forecast to grow at a 3.89% CAGR to 2031.
Which product segment is growing fastest through 2031?
Patient Warming Systems lead growth with a projected 5.12% CAGR, reflecting renewed perioperative volumes and stricter normothermia guidelines.
Why is neonatal temperature management gaining attention?
WHO 2024 guidance mandates therapeutic hypothermia for moderate-to-severe neonatal encephalopathy, boosting demand for servo-controlled blankets and caps and driving a 5.21% CAGR in neonatal and pediatric applications.
Which region will post the highest growth rate?
Asia-Pacific is projected to register a 5.05% CAGR, propelled by China’s healthcare infrastructure investments and India’s expanding surgical capacity.
What is driving demand for portable cooling devices?
Intensifying heatwaves have escalated heat-stroke emergencies, prompting emergency departments and field hospitals to procure rapid cooling systems that can lower core temperature below 39 °C within 30 minutes.
How concentrated is the supplier landscape?
The top five players hold about 45-50% of revenue, indicating moderate concentration with room for regional specialists and AI-centric entrants.




